This technique works by combining perfusion of lung tissue with biophoton therapy – red light targeting oxygen molecules within viral particles to cause irreparable damage and destroy them.
This case suggests that biophoton therapy may be an effective adjunctive modality to augment cellular energetics and support immune modulation during chemotherapy-radiation treatment, leading to improved outcomes and supporting improved immunity. Further controlled clinical studies should explore its potential as an approach for cancer therapy treatment.
1. Headache
Biophoton therapy devices release non-laser, near infrared light in packets called photons that work to break painful inflammation cycles by improving circulation and clearing away irritating cellular debris from tissues. They may also strengthen immune systems and stimulate nerve cells; often used for treating arthritis pain and improving quality of life.
One patient case study provides evidence that biophoton therapy can enhance cancer treatments such as chemotherapy and radiation. Patients undergoing both experienced increased tolerance to therapy, reduced side effects, fewer interruptions to regimens due to fatigue, nausea and pain as well as normal energy levels while on treatment, no infections during therapy and resumed work without interruption; Hematological parameters or other objective measures remained stable or returned to pretreatment values during their treatments; three out of the four achieved cancer remission with full cessation of chemotherapy therapies altogether.
This randomized, double-blind, placebo-controlled trial tests whether Tesla BioHealing Biophoton Generators can relieve arthritis pain for participants with chronic severe disease. Participants must agree to use the therapy device nightly for 12 or 24 weeks while filling out questionnaires and answering other relevant questions; details regarding whether patients must discontinue other medications will be provided by the research team.
2. Diarrhea
Biophoton therapy is a noninvasive, light-based form of photobiomodulation that uses photon absorption by mitochondrial chromophores in cells to activate a metabolic chain reaction that revitalizes and repairs tissues – similar to photosynthesis but done on humans instead.
Biophoton therapy produces energy that can be absorbed by cell membranes and used to energize and boost immunity, speed tissue healing, provide pain relief without opioid use and enhance daily functioning and quality of life. Furthermore, this form of therapy also improves ability to tolerate chemotherapy and radiation therapies by decreasing side effects.
Biophoton therapy not only has microbicidal and virucidal effects, but can also have profound ramifications on viral and bacterial genomes. UV light delivered via biophotons causes destabilizing changes to proteins and genomics found within viruses or bacteria resulting in denatured entities which are recognized by host immune systems as foreign entities that need to be destroyed quickly.
Biophoton therapy has proven itself as an effective method for treating HIV, Hepatitis C and MRSA; additionally it has been successful in eliminating drug resistant variants of these infectious agents. Although the molecular mechanisms remain unknown, biophotonic irradiation appears to play a part in disabling DNA and RNA damage to viruses and bacteria while inhibiting further in vitro replication or virucidal activity.
3. Fatigue
Clinical trials conducted on arthritis patients have demonstrated the efficacy of Biophoton Therapy as an alternative treatment option, alleviating both pain and improving mobility without experiencing side effects from traditional medication. The device emitting non-laser, near infrared photons helps break the painful inflammatory cycle by stimulating circulation and increasing cell activity – patients typically use it while sleeping overnight and fill out questionnaires about their progress as part of this therapy program.
Biophoton co-therapy may enhance cancer patients’ physiological resilience during chemotherapy and radiotherapy treatments, potentially alleviating treatment-related fatigue, pain and nausea. Unfortunately, few nonpharmacological modalities have been able to demonstrate these effects in real-world patients; the present case study provides both single patient observational data as well as broad observational analysis on biophoton co-therapy effects in postchemotherapy cancer patients using live blood dark-field microscopy as well as clinical observations.
Results demonstrate that this patient’s inflammatory biomarkers (e.g. squamous cell carcinoma antigen and neuron specific enolase) significantly improved, suggesting restored immune terrain, balanced biochemistry and possible support of remission support. Furthermore, the patient reported increased energy and sleep quality, regular bowel function, respiratory ease and overall wellness – indicators of improved metabolic function. According to data gathered during biophoton studies, biophotons appear to exert direct impact on intracellular physiology by means of mitochondrial chromophores absorption. Biophotons from laser light therapy activate a series of metabolic events that help revitalize and repair cells in your body, offering noninvasive therapy that can mitigate cancer treatments while improving overall outcomes.
4. Nausea
Biophoton therapy may cause nausea due to photobiomodulation. Photons penetrate cells and are absorbed by mitochondrial chromophores before stimulating metabolic processes that revitalize and repair tissues; similar to photosynthesis in plants. As a result, inflammation levels decrease while tissue healing increases significantly.
This case report details a lung cancer survivor exposed to biophoton fields for several days, experiencing gradual improvements in RBC morphology, plasma terrain clarity and overall recovery as seen by dark-field live blood microscopy and clinical observations. RBC morphology improved gradually along with plasma terrain clarity as observed clinically and objectively reported improved energy, sleep and bowel regularity; objective inflammatory markers like CEA also decreased, suggesting biophoton co-therapy may enhance recovery and resilience during conventional oncology treatment regimens.
Patients undergoing oncology treatments face the challenge of tolerating standard treatments without suffering side effects from them. Conventional chemotherapy and radiotherapy may be effective against tumors, but their side effects include metabolic dysfunction, immune suppression, systemic toxicity and systemic inflammation – which all have negative impacts on outcomes. Emerging non-pharmacological modalities have shown promise in improving cell health while alleviating treatment-related fatigue, nausea and weakness.
Biophoton Quantum Medicine (BQM) is one such modality. Utilizing a medical device to emit coherent ultraweak light emissions that stimulate the body’s natural healing mechanisms while decreasing side effects from conventional therapies, BQM utilises quantum biology and biophotonics as its foundation; BQM stands out among non-pharmacologic therapies by harnessing our bodies innate ability to generate and respond to quantum light emissions through mitochondrial chromophores where biophotons are absorbed to trigger metabolic pathways that support health while increasing immune response.
5. Vomiting
Research has demonstrated that most, if not all, cells emit invisible light known as biophotons that support basic functioning and influence cell proliferation. Scientists believe these photons also serve to communicate between cells; researchers have documented differences between tumor and healthy cell biophoton emissions patterns.
Researchers have recently discovered that biophoton therapy may help alleviate symptoms associated with rheumatoid arthritis (RA). Biophoton therapy has shown to increase grip strength and decrease morning stiffness for those living with RA. Furthermore, inflammation levels are reduced while blood flow increases significantly; biophoton therapy helps alleviate pain caused by nerves, joints and muscles affected by RA while simultaneously improving quality of life for these individuals.
This clinical trial will investigate if a new device that emits biophotons through a special light can effectively ease chronic severe arthritis pain in adults over three months who have experienced symptoms related to R.A. You will either receive the active device that emits biophotons or a placebo device. It is a randomized, double-blind and placebo controlled intervention clinical trial.
Case study results were presented for a 72-year-old lung cancer survivor receiving nightly biophoton co-therapy for 24 days, including five time point analyses on peripheral blood samples from five time points post treatment for red blood cell morphology, white blood cell behavior, plasma terrain analysis. Biophoton co-therapy significantly enhanced physiological conditions favoring remission and normalized carcinoembryonic antigen (CEA) levels within 24 days; participants experienced significant improvements in subjective symptoms as well as energy level improvements as part of treatment.
